We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Sindall Group Regulatory News (MGNS)

Share Price Information for Morgan Sindall Group (MGNS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,265.00
Bid: 2,255.00
Ask: 2,270.00
Change: 10.00 (0.44%)
Spread: 15.00 (0.665%)
Open: 2,255.00
High: 2,290.00
Low: 2,240.00
Prev. Close: 2,255.00
MGNS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorship Changes

12 Dec 2023 07:00

RNS Number : 3963W
Morgan Sindall Group PLC
12 December 2023
 

 

12 December 2023

 

 

Morgan Sindall Group plc

 

Directorship changes

 

Morgan Sindall Group plc (the 'Company') today announces that Steve Crummett, Finance Director, has informed the Board of his intention to retire from the Company on 31 December 2024.

 

The Board also announces that following a search process, Kelly Gangotra, currently Chief Financial Officer, Healthcare Sector at Halma plc and previously Chief Financial Officer of Skanska UK, has been selected to succeed Steve as Finance Director.

 

Kelly will be appointed as Finance Director and become a member of the Board on a date to be agreed, expected to be around the third quarter of 2024, when Steve will step down from both roles. This will then allow for a period of transition until Steve retires from the Company at the end of the year.

 

John Morgan, Group Chief Executive Officer said: "I'd like to thank Steve for his exceptional contribution to the Board over the last ten years. Steve has seen the business through a period of significant growth and has helped shape our strategic direction and ensured that the financial stewardship of the business over the last 10 years has supported the Group's long term growth.

 

"I am delighted that Kelly will join the Group in 2024 and I look forward to working with her over the years ahead. She has an excellent track record as a CFO working in a decentralised business, is highly experienced in the construction and property industry and her valuable and significant skills and insight will support me and the Board as the Group continues to develop and grow." 

 

ENDS

A statement concerning particulars of remuneration payments in accordance with section 430(2B) of the Companies Act 2006 will be published in due course.

 

Note to Editors

Morgan Sindall Group

Morgan Sindall Group plc is a leading UK Construction & Regeneration group with annual revenue of £3.6bn, employing around 7,600 employees and operating in the public, regulated and private sectors. It reports through six divisions of Construction, Infrastructure, Fit Out, Property Services, Partnership Housing and Urban Regeneration.

 

Kelly Gangotra

 

Kelly has extensive financial and commercial leadership experience across the construction and property sectors and has served as the CFO of the Healthcare division of Halma plc since August 2022. Prior to Halma, Kelly spent a decade with Skanska Plc in the UK where she was firstly Finance Director from 2012 to 2015 and then CFO and Executive Vice President between 2015 and 2022. She has also held senior finance roles at Alliance Medical and Biffa Waste Services.

 

There are no other details requiring disclosure under Listing Rule 9.6.13 in relation to Kelly Gangotra.

 

 

 

Morgan Sindall Group

Michael Findlay (Chair)

John Morgan

 

Brunswick

Jonathan Glass

Nina Coad

Tel: 020 7307 9200

 

 

 

Tel: 020 7404 5959

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAGPGAGPUPWGMG
Date   Source Headline
22nd Apr 202410:35 amRNSBlock listing Interim Review
8th Apr 20247:00 amRNSDirectorate Changes: Update
2nd Apr 202412:38 pmRNSTotal Voting Rights
21st Mar 20242:17 pmRNSAnnual Financial Report
19th Mar 20243:45 pmRNSAdditional Listing
5th Mar 20243:05 pmRNSDirector/PDMR Shareholding
5th Mar 20243:04 pmRNSDirector/PDMR Shareholding
5th Mar 20242:53 pmRNSDirector/PDMR Shareholding
4th Mar 20243:49 pmRNSDirector/PDMR Shareholding
4th Mar 20243:49 pmRNSDirector/PDMR Shareholding
1st Mar 20243:19 pmRNSTotal Voting Rights
22nd Feb 20247:00 amRNSRESULTS FOR THE FULL YEAR ENDED 31 DECEMBER 2023
5th Feb 20247:00 amRNSNotice of Full Year Results
1st Feb 202410:25 amRNSTotal Voting Rights
19th Jan 20244:14 pmRNSHolding(s) in Company
17th Jan 20245:11 pmRNSHolding(s) in Company
12th Jan 20243:25 pmRNSHolding(s) in Company
2nd Jan 202412:21 pmRNSTotal Voting Rights
12th Dec 20237:00 amRNSDirectorship Changes
7th Dec 20235:40 pmRNSHolding(s) in Company
6th Dec 20234:33 pmRNSHolding(s) in Company
1st Dec 202312:13 pmRNSTotal Voting Rights
23rd Nov 20237:00 amRNSDirectorship Changes
22nd Nov 20232:31 pmRNSAdditional Listing
3rd Nov 20234:15 pmRNSHolding(s) in Company
2nd Nov 20237:00 amRNSTrading Update
1st Nov 202311:14 amRNSTotal Voting Rights
26th Oct 20234:43 pmRNSHolding(s) in Company
20th Oct 20239:05 amRNSBlock listing Interim Review
10th Oct 202311:44 amRNSAdditional Listing
12th Sep 20233:12 pmRNSHolding(s) in Company
4th Sep 202312:51 pmRNSAGM Voting Update
1st Sep 20239:45 amRNSTotal Voting Rights
22nd Aug 20233:56 pmRNSAdditional Listing
10th Aug 202311:50 amRNSDirector/PDMR Shareholding
10th Aug 202311:45 amRNSDirector/PDMR Shareholding
2nd Aug 20236:30 pmRNSResults for the Half Year (HY) Ended 30 June 2023
1st Aug 202311:13 amRNSTotal Voting Rights
10th Jul 20237:00 amRNSNotice of Half Year Results
3rd Jul 202310:37 amRNSTotal Voting Rights
29th Jun 20237:00 amRNSTrading Update
14th Jun 20232:10 pmRNSAdditional Listing
14th Jun 20239:13 amRNSHolding(s) in Company
12th Jun 20233:50 pmRNSHolding(s) in Company
1st Jun 20239:16 amRNSTotal Voting Rights
31st May 20234:10 pmRNSHolding(s) in Company
10th May 202311:19 amRNSAdditional Listing
5th May 20232:38 pmRNSHolding(s) in Company
4th May 202312:44 pmRNSResult of AGM
4th May 20237:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.